Workflow
Clorox Scentiva Bleach
icon
Search documents
Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
Prnewswire· 2026-02-03 21:10
Core Insights - The Clorox Company reported second-quarter results for fiscal year 2026, indicating a generally stable performance amid a challenging environment, allowing the company to reaffirm its fiscal year outlook [2][8] - The company is focused on executing its strategic priorities, including a significant acquisition of GOJO Industries to enhance its health and hygiene portfolio [2][6] Financial Performance - Net sales decreased by 1% to $1.67 billion, primarily due to lower consumption, with organic sales also down by 1% [5][10] - Gross margin fell by 60 basis points to 43.2%, attributed to increased manufacturing and logistics costs, partially offset by cost savings [5][10] - Diluted net earnings per share (EPS) decreased by 16% to $1.29, while adjusted EPS fell by 10% to $1.39 [5][29] Strategic and Operational Highlights - The Health and Wellness segment saw a 2% increase in net sales, driven by higher volume from ERP transition shipments and strong Professional Products sales [4][10] - The company completed the final phase of its U.S. ERP implementation, marking a significant milestone in its digital transformation [6] - New product introductions included Clorox PURE and expanded offerings in various brands, contributing to innovation efforts [6] Fiscal Year 2026 Outlook - The company maintains its full-year outlook for net sales, gross margin, and adjusted EPS, expecting a decrease in net sales of 6% to 10% [8][11] - The anticipated impact from inventory drawdown due to prior ERP transition shipments is expected to reduce fiscal year 2026 EPS by approximately 90 cents [9][11] - The company expects organic sales to decrease by 5% to 9%, with a significant impact from the reversal of prior year shipment effects [11][12] Segment Performance - The Household segment experienced a 6% decrease in net sales, while the Lifestyle segment saw a 5% decline [10][36] - The International segment reported a 7% increase in net sales, driven by favorable price mix and foreign exchange rates [10][36] - Adjusted EBIT for the Household segment decreased by 54%, primarily due to higher costs and lower sales [10][36]
Clorox (CLX) Q4 EPS Jumps 58%
The Motley Fool· 2025-08-02 08:44
Core Insights - Clorox reported a significant increase in adjusted EPS to $2.87, surpassing analyst expectations of $2.20, with GAAP revenue reaching $1.99 billion, exceeding the forecast of $1.93 billion [1][2] - The strong performance was primarily driven by one-time "incremental ERP shipments" ahead of a digital system upgrade, which is not expected to recur [1][5] - Management anticipates lower sales and profits for FY2026, projecting a decline in net sales by 6% to 10% and adjusted EPS down by 18% to 23% [1][10] Financial Performance - Adjusted EPS increased by 57.7% year-over-year from $1.82 in Q4 2024 to $2.87 in Q4 2025 [2] - GAAP revenue grew by 4.7% year-over-year from $1.90 billion in Q4 2024 to $1.99 billion in Q4 2025 [2] - Operating cash flow increased by 41% in FY2025, reaching $981 million, while cash and equivalents declined to $167 million as of June 30, 2025 [6] Segment Performance - Health & Wellness segment net sales grew by 14%, with adjusted EBIT increasing by 20% [7] - Household segment net sales rose by 7%, with EBIT jumping 59%, both inflated by one-time volume surges [7] - Lifestyle segment net sales increased by 3%, reflecting innovation and reduced advertising [7] Strategic Focus - Clorox is prioritizing brand equity, supply chain management, product innovation, and digital transformation [4] - The company is investing over $570 million in digital technology to modernize operations and improve analytics [9] - Corporate responsibility and sustainability efforts, including waste and emissions reduction, are key components of the company's strategy [4] Future Outlook - Management expects organic sales to decline by 5% to 9% in FY2026, with gross margin compressing by 50 to 100 basis points [10] - The company faces $100 million in annualized cost pressure from new import tariffs starting in early FY2026 [9] - Investors will monitor Clorox's ability to manage inventory normalization, tariff impacts, and shifts in consumer behavior [11]